MPC Therapeutics

MPC Therapeutics

Signal active

Organization

Contact Information

Overview

MPC Therapeutics is a biotechnology company. For patients with cancer and degenerative disorders, the company is presently concentrating on creating life-altering medications. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.

About

Industries

Biotechnology, Health Care, Medical

Founded

2018

Employees

1-10

Headquarters locations

Plan-les-ouates, Geneve, Switzerland, Europe

Social

Profile Resume

MPC Therapeutics headquartered in Switzerland, Europe, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $202.1M in funding across 72 round(s). With a team of 1-10 employees, MPC Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - MPC Therapeutics, raised $112.5K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Raphael Martinou

Raphael Martinou

Co-founder & CEO

imagePlace Augustin de Bettignies

Augustin de Bettignies

Co-Founder and Chief Business Officer

Funding Rounds

Funding rounds

6

Investors

1

Lead Investors

0

Total Funding Amount

$2.8M

Details

1

MPC Therapeutics has raised a total of $2.8M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2023Seed1.6M

Investors

MPC Therapeutics is funded by 9 investors.

Investor NameLead InvestorFunding RoundPartners
MPC Therapeutics-FUNDING ROUND - MPC Therapeutics1.6M
Plutus Investment Group-FUNDING ROUND - Plutus Investment Group1.6M
MPC Therapeutics-FUNDING ROUND - MPC Therapeutics112.5K
FONGIT Innovation Fund-FUNDING ROUND - FONGIT Innovation Fund112.5K